API Product   :    Ropinirole HCI
CEP   :    ¤
WCC   :    ?
Therapeutic Use    :    Anti-Parkinson Drugs; Psycholeptics
Anti-Parkinson Drugs; Psycholeptics
Originator   :    GlaxoSmithKline
CAS No.    :    91374-21-9
Trade Name.   :    Requip
Molecular Weight   :    260.375 g/mol
Molecular Formula   :    C16H24N2O
Ropinirole is also used to treat restless legs syndrome (RLS). It may improve your sleep by decreasing the urge to move your legs and decreasing uncomfortable/unpleasant feelings in the legs. This medication works by helping to restore the balance of a certain natural substance (dopamine) in the brain.
Ropinirole (INN; trade names Requip, Repreve, Ronirol, Adartrel) is a dopamine agonist of the non-ergoline class of medications. It is manufactured by GlaxoSmithKline (GSK), Cipla, Dr. Reddy's Laboratories and Sun Pharmaceutical. It is used in the treatment of Parkinson's disease and restless legs syndrome (RLS). Ropinirole is one of three medications approved by the FDA to treat RLS, the other two being pramipexole (Mirapex) and gabapentin enacarbil (Horizant). The discovery of the drug's utility in RLS has been used as an example of successful drug repurposing.